Category: InVivo Therapeutics Corp.
Here's a look at some of the top legal news stories for medical device companies this week: Mirowski wants another bite at Supreme Court apple in Medtronic lawsuit; Shareholders sue InVivo Therapeutics, ex-CEO Reynolds over delayed FDA trial; Retractable Technologies urges appeals court to leave infringement win over BD alone; Boston Scientific can't sever Pinnacle pelvic mesh cases; Allergan can't delay shareholder vote on hostile Valeant bid
Shareholders sue InVivo Therapeutics and former CEO Frank Reynolds, alleging that the company concealed how long it would take to run a clinical trial under FDA guidelines.
Jorge Quinoy, president of Volcano Corp.'s U.S. & APLAC commercial sales, is leaving the company effective today.
Volcano (NSDQ:VOLC) said last week that its president for U.S. & APLAC commercial sales, Jorge (George) Quinoy, is leaving the company effective today.
Here's a look at some of the top funding stories for medical device companies this week: Intersect ENT registers $80M IPO for sinus implants; Mitralign raises another $8M; Device makers tally $67M in Pentagon deals; EndoShape raises $6.8M for vascular plugs and coils; EMBA Medical's still working on its $3M funding round
InVivo Therapeutics scales back its hydrogel delivery program, cutting nearly 1/3rd of its workforce to focus resources on its neuro-scaffold product line.
Hologic, Welch Allyn, InVivo, Digirad and ICAD claim nearly $67 million in medtech contracts with the Dept. of Defense.
The Defense Dept. handed out some $66.7 million in supply contracts to 5 medical device makers, covering Pap test kits, radiology and patient monitoring systems.
Sunshine Heart taps ex-Boston Scientific cardiovascular R&D veteran Brian Brown as its new vice president for operations & technology.